2 results
Approved WMORecruiting
Nemo Healthcare B.V. recently developed a new technique for monitoring the unborn baby. This technique is already widely used in unborn babies over 37 weeks of gestational age. The purpose of this study is to examine if that new technique is also…
Approved WMORecruiting
Primary objective:- To assess the long-term safety and tolerability of efgartigimod PH20 SC (efgartigimod co formulated with recombinant human hyaluronidase PH20 [rHuPH20] for subcutaneous [SC] administration).Secondary objectives:- To determine the…